300 million paediatric antimalarial treatments delivery milestone
Coartem Dispersible, the first WHO prequalified pediatric antimalarial treatment, has become the standard of care in over 30 malaria-endemic countries Since 2009, Novartis has supplied 300 million Coartem Dispersible treatments...
Read More